Regions :: Southeast Asia
Lonza to Build Cell Therapy Production Facility in Singapore
10:23 AM MDT | May 22, 2009 | DEEPTI RAMESH
Lonza says it will build a cell therapy facility in Singapore to expand its global presence and meet growing worldwide demand. Lonza will invest SF30 million ($27 million) in the first construction phase of the plant, which will be located adjacent to Lonza’s large-scale mammalian cell culture facility at Tuas Biomedical Park. Construction is expected to begin in early 2010, with start up of two suites by mid-2011. Borgas: Cell therapy to become important innovation driver. The facility will be designed to accommodate additional suites to meet...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee